🎙️ CIC 2024: NACI, Real World Evidence and  Pharmacoeconomic Modeling with Dr. Jesse Papenburg 🎙️

We sit down with dynamic public health leader and clinician scientist Dr. Jesse Papenburg—a member of the National Advisory Committee on Immunization (NACI) and the Quebec Immunization Committee, where he leads the influenza and RSV working groups, respectively,  and the voice behind some of the latest vaccine recommendations 💉.

We unpack the science behind high-dose, adjuvanted, and recombinant influenza vaccines 🧬🩺, specifically tailored for adults 65+. Discover how these specialized vaccines offer enhanced protection by boosting immune responses where it counts the most 🚀💪.

Dr. Jesse Papenburg also sheds light on the groundbreaking RSV vaccines designed to shield older adults from severe respiratory illnesses 🤧🛡️

• With behind the scenes insights into how cost-effectiveness, real-world efficacy, and economic modeling factor behind NACI's recommendations 📊💡, this episode delivers both the technical deep dive and the human touch that brings public health to life ❤️.

And for a refreshing twist, learn about Jesse Papenburg's off-duty passion 😎🥏.

Learning Objectives:

1. Decipher the Vaccine Jargon:
   Understand why high-dose, adjuvanted, and recombinant influenza vaccines are revolutionizing protection for adults 65+ and 75+ 🕵️‍♂️💉.
2. RSV Revealed:
   Gain insight into the new RSV vaccines for seniors, how they reduce the risk of severe respiratory infections, and why they're becoming a critical tool in our public health arsenal 🛡️📊.
3. Risk Factors & Real Talk:
   Explore how age, comorbidities, and living environments like long-term care facilities amplify risks—and why personalized vaccine strategies are essential in today’s healthcare landscape 🏥🔍.
4. Tech Talk + Public Health:
   Delve into the emerging role of AI and predictive modeling in shaping future vaccination policies, offering a fresh perspective on how data-driven insights are changing the game 🤖🚀
5. NACI's Art of Decision Making:
    Behind the scenes insights into how cost-effectiveness, real-world efficacy, and economic modeling factor behind NACI's recommendations 📊💡

Whether you're a healthcare provider seeking the latest evidence-based updates or a public health policy buff, this episode promises a perfect blend of scientific rigor, practical insights, and a dash of fun! 🎧✨

About Dr. Jesse Papenburg

Dr. Jesse Papenburg practices Pediatric Infectious Diseases and Medical Microbiology at the Montreal Children’s Hospital of the McGill University Health Centre.

After his specialty training, Dr. Papenburg completed a research fellowship on the molecular virology of RNA respiratory viruses at Laval University and an MSc in epidemiology at McGill. As a clinician scientist, he studies the epidemiology of viral respiratory infections. Dr. Papenburg is a member of the National Advisory Committee on Immunization and the Quebec Immunization Committee where he leads the influenza and RSV working groups, respectively.